|
Eli Lilly
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$1034
|
$958B |
15.4x |
34.4x |
|
Johnson & Johnson
|
United States of America |
Biopharmaceuticals,
Medical Devices,
Drug Development & Therapeutics
|
$205
|
$522B |
5.6x |
14.7x |
|
AbbVie
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Health & Beauty
|
$224
|
$460B |
7.6x |
17.9x |
|
Merck & Co
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$101
|
$274B |
4.2x |
9.4x |
|
Amgen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$338
|
$227B |
6.3x |
12.7x |
|
Pfizer
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$25
|
$189B |
3.0x |
7.6x |
|
Gilead Sciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$125
|
$173B |
5.9x |
11.1x |
|
Bristol-Myers Squibb
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$51
|
$138B |
2.9x |
7.8x |
|
Vertex Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics,
Regenerative Medicine
|
$433
|
$105B |
8.8x |
20.8x |
|
Regeneron Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$724
|
$70.3B |
4.9x |
13.9x |
|
Zoetis
|
United States of America |
Pet Care,
Biopharmaceuticals,
Drug Development & Therapeutics
|
$124
|
$60.0B |
6.4x |
14.6x |
|
Alnylam Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$465
|
$60.0B |
16.6x |
91.1x |
|
Insmed
|
United States of America |
Drug Development & Therapeutics
|
$207
|
$43.0B |
86.2x |
-38.1x |
|
Biogen
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$181
|
$29.1B |
3.0x |
9.5x |
|
Viatris
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$11
|
$26.0B |
1.8x |
6.3x |
|
United Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$481
|
$17.6B |
5.5x |
10.6x |
|
Incyte
|
United States of America |
Drug Development & Therapeutics
|
$102
|
$17.0B |
3.5x |
11.5x |
|
BridgeBio Pharma
|
United States of America |
Drug Development & Therapeutics
|
$74
|
$15.5B |
32.7x |
-33.3x |
|
Elanco
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$14.5B |
3.1x |
16.4x |
|
Neurocrine Biosciences
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$152
|
$14.5B |
5.1x |
21.8x |
|
Jazz Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$167
|
$13.5B |
3.2x |
13.9x |
|
Summit Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$18
|
$13.4B |
N/A |
-13.9x |
|
Revolution Medicines
|
United States of America |
Drug Development & Therapeutics
|
$78
|
$13.2B |
4105.4x |
-12.1x |
|
Ionis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$81
|
$12.4B |
14.1x |
-33.2x |
|
Madrigal Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$580
|
$12.4B |
13.9x |
-40.9x |
|
Exelixis
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$10.8B |
4.7x |
11.7x |
|
Roivant Sciences
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$21
|
$10.1B |
514.1x |
-9.2x |
|
Organon
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$7
|
$10.0B |
1.6x |
5.2x |
|
BioMarin Pharmaceutical
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$54
|
$9.6B |
3.0x |
12.5x |
|
Avidity Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$72
|
$9.0B |
502.9x |
-13.7x |
|
Halozyme Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$65
|
$8.4B |
6.4x |
9.8x |
|
Corcept Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$84
|
$8.4B |
10.4x |
N/A |
|
Arrowhead Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$8.3B |
11.0x |
119.0x |
|
Cytokinetics
|
United States of America |
Drug Development & Therapeutics
|
$65
|
$8.1B |
103.7x |
-13.7x |
|
Nuvalent
|
United States of America |
Drug Development & Therapeutics
|
$107
|
$7.4B |
N/A |
-18.4x |
|
Axsome Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$148
|
$7.3B |
12.0x |
-43.6x |
|
Rhythm Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$105
|
$6.7B |
36.6x |
-34.3x |
|
Merus
|
United States of America |
Drug Development & Therapeutics
|
$96
|
$6.7B |
127.3x |
-19.4x |
|
BioNTech
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$97
|
$6.7B |
2.2x |
-5.6x |
|
Cidara Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$221
|
$6.5B |
69316.3x |
N/A |
|
Regencell Bioscience
|
United States of America |
Drug Development & Therapeutics
|
$13
|
$6.4B |
N/A |
N/A |
|
Amneal Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$12
|
$6.3B |
2.1x |
9.3x |
|
Moderna
|
United States of America |
Vaccines & Immunotherapies,
Drug Development & Therapeutics
|
$25
|
$6.1B |
3.0x |
-1.9x |
|
Cogent Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$5.8B |
N/A |
-21.8x |
|
Krystal Biotech
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$215
|
$5.5B |
14.5x |
34.1x |
|
Belite Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$152
|
$5.4B |
N/A |
N/A |
|
TG Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$32
|
$5.1B |
8.8x |
39.1x |
|
Perrigo
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$14
|
$5.1B |
1.2x |
7.0x |
|
PTC Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$76
|
$4.8B |
2.8x |
5.6x |
|
Protagonist Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$85
|
$4.7B |
52.5x |
-40.8x |
|
Apogee Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$75
|
$4.6B |
N/A |
-16.9x |
|
Legend Biotech
|
United States of America |
Drug Development & Therapeutics
|
$28
|
$4.5B |
4.5x |
-30.7x |
|
Celcuity
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$100
|
$4.5B |
N/A |
-27.7x |
|
Praxis Precision Medicines
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$186
|
$4.4B |
4816.6x |
-15.1x |
|
Kymera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$66
|
$4.3B |
81.8x |
-13.9x |
|
Lantheus Holdings
|
United States of America |
Medical Imaging & Diagnostics,
Drug Development & Therapeutics
|
$60
|
$4.2B |
2.8x |
7.6x |
|
Scholar Rock
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$44
|
$4.2B |
N/A |
-10.8x |
|
Alkermes
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$30
|
$3.8B |
2.6x |
10.0x |
|
Prestige Consumer Healthcare
|
United States of America |
Health & Beauty,
Drug Development & Therapeutics
|
$60
|
$3.8B |
3.4x |
10.4x |
|
Arcellx
|
United States of America |
Drug Development & Therapeutics
|
$73
|
$3.8B |
99.6x |
-15.6x |
|
Akero Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$55
|
$3.8B |
N/A |
-11.0x |
|
CRISPR Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$56
|
$3.6B |
368.0x |
-6.2x |
|
Arcutis Biotherapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$30
|
$3.6B |
10.4x |
-320.0x |
|
Mirum Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$71
|
$3.6B |
7.2x |
-650.9x |
|
ACADIA Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$26
|
$3.6B |
3.3x |
29.6x |
|
Ligand Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$193
|
$3.6B |
13.9x |
35.7x |
|
NewAmsterdam Pharma Co
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$36
|
$3.3B |
116.8x |
N/A |
|
Viking Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$35
|
$3.3B |
N/A |
-10.3x |
|
Immunovant
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$3.3B |
N/A |
-6.5x |
|
Crinetics Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$45
|
$3.2B |
668.5x |
-6.9x |
|
Amicus Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Regenerative Medicine
|
$10
|
$3.2B |
5.1x |
34.8x |
|
Travere Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$35
|
$3.2B |
6.7x |
-480.5x |
|
Tarsus Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$82
|
$3.1B |
7.4x |
-46.7x |
|
Ultragenyx
|
United States of America |
Drug Development & Therapeutics
|
$36
|
$3.1B |
4.8x |
-6.3x |
|
Liquidia
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$34
|
$3.0B |
21.3x |
N/A |
|
Xenon Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$44
|
$3.0B |
424.2x |
-8.4x |
|
Disc Medicine
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$92
|
$2.9B |
N/A |
-12.7x |
|
Ascentage Pharma
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$31
|
$2.9B |
36.5x |
-22.8x |
|
CG Oncology
|
United States of America |
Drug Development & Therapeutics
|
$43
|
$2.8B |
997.4x |
-14.5x |
|
Kiniksa Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$41
|
$2.7B |
4.2x |
28.5x |
|
Viridian Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$31
|
$2.7B |
34.2x |
-9.9x |
|
Sarepta Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$22
|
$2.7B |
1.3x |
-8.7x |
|
Alvotech
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$5
|
$2.7B |
4.7x |
21.4x |
|
Apellis Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$21
|
$2.7B |
2.7x |
45.3x |
|
Mineralys Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$39
|
$2.5B |
N/A |
-13.1x |
|
Adaptive Biotech
|
United States of America |
Pharma Diagnostics & Analytics,
Drug Development & Therapeutics
|
$17
|
$2.5B |
9.6x |
-324.6x |
|
Arcus Biosciences
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals,
Vaccines & Immunotherapies
|
$26
|
$2.5B |
9.9x |
-6.9x |
|
ImmunityBio
|
United States of America |
Drug Development & Therapeutics,
Vaccines & Immunotherapies
|
$2
|
$2.4B |
23.6x |
N/A |
|
Nuvation Bio
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$8
|
$2.4B |
46.4x |
N/A |
|
Phibro Animal Health
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$2.4B |
1.7x |
11.5x |
|
Spyre Therapeutics
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$32
|
$2.3B |
N/A |
-11.0x |
|
Supernus Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$45
|
$2.3B |
3.3x |
17.8x |
|
Soleno Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$51
|
$2.3B |
13.5x |
N/A |
|
IDEAYA Biosciences
|
United States of America |
Drug Development & Therapeutics
|
$34
|
$2.3B |
11.2x |
-13.4x |
|
Vera Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$41
|
$2.2B |
N/A |
-7.7x |
|
ANI Pharmaceuticals
|
United States of America |
Biopharmaceuticals,
Drug Development & Therapeutics
|
$83
|
$2.2B |
2.6x |
10.0x |
|
Dyne Therapeutics
|
United States of America |
Drug Development & Therapeutics
|
$20
|
$2.2B |
N/A |
-5.1x |
|
Terns Pharma
|
United States of America |
Drug Development & Therapeutics,
Biopharmaceuticals
|
$27
|
$2.2B |
N/A |
-19.6x |
|
Ocular Therapeutix
|
United States of America |
Drug Development & Therapeutics,
Drug Delivery Systems
|
$11
|
$2.2B |
39.1x |
-8.4x |
|
Catalyst Pharmaceuticals
|
United States of America |
Drug Development & Therapeutics
|
$23
|
$2.2B |
3.8x |
7.9x |